What's new

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Status: Authorised

Mar 3, 2025 - 16:01
 0
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetiu...

Next Article

Texas system creates 3 new CEO roles

Related Posts

Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 9, 2025  0

Herbal medicinal product: Cynarae folium, Cynara cardunculus L.,syn. C. scolymus L., C: ongoing call for scientific data

Herbal medicinal product: Cynarae folium, Cynara cardun...

Mar 13, 2025  0